WASHINGTON (Reuters) - Novartis AG and Astellas Pharma eczema drugs may need their warning labels expanded after dozens of new reported cases of cancer and infection in children, U.S. Food and Drug Administration staff said in documents released on Thursday.
Agency scientists said 46 cancer cases and 71 infection cases ...More
WASHINGTON (Reuters) - House Majority Leader Steny Hoyer said on Thursday that sweeping healthcare overhaul legislation was on track for passage by the U.S. House of Representatives and would cut the deficit by more than $100 billion in the first 10 years.
Expanding healthcare coverage will cost about $940 billion ...More
ZURICH (Reuters) - Roche Holding AG is aiming to launch at least six new products by the end of 2014 and is seeking to further boost its position in areas outside oncology, the Swiss drugmaker said ahead of its investor day.
Roche, the world's largest maker of cancer drugs, is ...More
LONDON (Reuters) - A pioneering -- but much delayed -- cannabis-based medicine for multiple sclerosis is now on track to win regulatory approval in Britain and Spain in the second quarter of 2010, its maker said on Thursday.
GW Pharmaceuticals said regulators in both countries had concluded there were no major quality, safety ...More
BEIJING (Reuters) - China's Health Ministry is probing a report in a domestic newspaper that faulty vaccines in northern Shanxi province were responsible for killing four children and making dozens of others sick.
China has been beset by a series of product safety scandals over the past few years. At ...More
WASHINGTON (Reuters) - A Senate Democrat asked top drugmakers on Wednesday to explain why Americans pay higher prices for prescription drugs than patients do in other developed nations.
Senator Herb Kohl, who chairs the Special Committee on Aging, sent letters to AstraZeneca, GlaxoSmithKline, Eli Lilly, Novartis, Pfizer, and Sanofi-Aventis.
Kohl said ...More
BOSTON (Reuters) - Studying genes linked to breast cancer may someday lead to better treatments, but they do little to improve a doctor's ability to predict who is likely to develop a tumor, researchers reported on Wednesday.
Their study in the New England Journal of Medicine found that testing for ...More
NEW YORK (Reuters Health) - Wider dissemination of portable defibrillators in Japan's schools, workplaces and other public venues has increased the number of people who survive cardiac arrest, researchers reported Wednesday.
Experts say the findings, reported in the New England Journal of Medicine, support efforts to make the devices, known ...More
CHICAGO (Reuters) - Instead of killing off cancer cells with toxic drugs, scientists have discovered a molecular pathway that forces them to grow old and die, they said on Wednesday.
Cancer cells spread and grow because they can divide indefinitely.
But a study in mice showed that blocking a cancer-causing gene ...More
NEW YORK (Reuters Health) - Despite supplement makers' claims and popular perceptions, the benefits of soy in fighting hot flashes in women going through menopause remain unproven, according to a new analysis of 19 studies.
Soy contains estrogen-like compounds, and researchers have proposed that the amount of soy a woman consumes ...More
